Your browser doesn't support javascript.
loading
The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat GPR35.
MacKenzie, Amanda E; Caltabiano, Gianluigi; Kent, Toby C; Jenkins, Laura; McCallum, Jennifer E; Hudson, Brian D; Nicklin, Stuart A; Fawcett, Lindsay; Markwick, Rachel; Charlton, Steven J; Milligan, Graeme.
Afiliación
  • MacKenzie AE; Molecular Pharmacology Group, Institute of Molecular, Cell, and Systems Biology (A.E.M., G.C., L.J., J.E.M., B.D.H., G.M.) and Institute of Cardiovascular and Medical Sciences, (J.E.M., S.A.N.), College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom; Laboratory of Computational Medicine, Biostatistics Unit, Faculty of Medicine, Autonomous University of Barcelona, Bellaterra, Spain (G.C.); and Novartis Institutes for Biomedical Research, Horsham
Mol Pharmacol ; 85(1): 91-104, 2014 Jan.
Article en En | MEDLINE | ID: mdl-24113750
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Ácido Oxámico / Fenantrolinas / Antialérgicos / Receptores Acoplados a Proteínas G / Mastocitos Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Pharmacol Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Ácido Oxámico / Fenantrolinas / Antialérgicos / Receptores Acoplados a Proteínas G / Mastocitos Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Pharmacol Año: 2014 Tipo del documento: Article